nodes	percent_of_prediction	percent_of_DWPC	metapath
Tirofiban—ITGA2B—Arf6 signaling events—TSHR—thyroid cancer	0.0427	0.0608	CbGpPWpGaD
Tirofiban—ITGA2B—ECM proteoglycans—LAMA2—thyroid cancer	0.0359	0.0511	CbGpPWpGaD
Tirofiban—ITGA2B—thyroid gland—thyroid cancer	0.0355	0.329	CbGeAlD
Tirofiban—ITGB3—Non-integrin membrane-ECM interactions—LAMA2—thyroid cancer	0.0343	0.0488	CbGpPWpGaD
Tirofiban—ITGB3—Arf6 signaling events—TSHR—thyroid cancer	0.0329	0.0468	CbGpPWpGaD
Tirofiban—ITGA2B—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L1—thyroid cancer	0.0321	0.0456	CbGpPWpGaD
Tirofiban—ITGB3—thyroid gland—thyroid cancer	0.031	0.288	CbGeAlD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—CITED1—thyroid cancer	0.0308	0.0437	CbGpPWpGaD
Tirofiban—ITGA2B—Hematopoietic Stem Cell Differentiation—EPO—thyroid cancer	0.0301	0.0429	CbGpPWpGaD
Tirofiban—ITGA2B—Arrhythmogenic Right Ventricular Cardiomyopathy—LAMA2—thyroid cancer	0.0283	0.0403	CbGpPWpGaD
Tirofiban—ITGB3—ECM proteoglycans—LAMA2—thyroid cancer	0.0277	0.0394	CbGpPWpGaD
Tirofiban—ITGB3—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L1—thyroid cancer	0.0247	0.0351	CbGpPWpGaD
Tirofiban—ITGB3—Hematopoietic Stem Cell Differentiation—EPO—thyroid cancer	0.0232	0.033	CbGpPWpGaD
Tirofiban—ITGA2B—lymph node—thyroid cancer	0.022	0.204	CbGeAlD
Tirofiban—ITGB3—Arrhythmogenic Right Ventricular Cardiomyopathy—LAMA2—thyroid cancer	0.0218	0.031	CbGpPWpGaD
Tirofiban—ITGB3—lymph node—thyroid cancer	0.0193	0.179	CbGeAlD
Tirofiban—Haemoglobin decreased—Vandetanib—thyroid cancer	0.0175	0.0926	CcSEcCtD
Tirofiban—Haemoptysis—Vandetanib—thyroid cancer	0.0163	0.0861	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—LAMA2—thyroid cancer	0.0133	0.019	CbGpPWpGaD
Tirofiban—Haemoglobin decreased—Sorafenib—thyroid cancer	0.0118	0.0624	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—LAMA2—thyroid cancer	0.0103	0.0146	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—LAMA2—thyroid cancer	0.0102	0.0146	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—CDK1—thyroid cancer	0.00913	0.013	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—CDK1—thyroid cancer	0.00861	0.0122	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin alphaIIb beta3 signaling—AKT1—thyroid cancer	0.00826	0.0117	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—LAMA2—thyroid cancer	0.00789	0.0112	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—CDK1—thyroid cancer	0.00772	0.011	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—BRAF—thyroid cancer	0.00749	0.0106	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—BRAF—thyroid cancer	0.00714	0.0101	CbGpPWpGaD
Tirofiban—Haematuria—Vandetanib—thyroid cancer	0.00642	0.034	CcSEcCtD
Tirofiban—ITGA2B—Platelet Aggregation (Plug Formation)—AKT1—thyroid cancer	0.00642	0.00913	CbGpPWpGaD
Tirofiban—ITGB3—Integrin alphaIIb beta3 signaling—AKT1—thyroid cancer	0.00636	0.00905	CbGpPWpGaD
Tirofiban—Bradycardia—Vandetanib—thyroid cancer	0.00615	0.0326	CcSEcCtD
Tirofiban—Haemoglobin—Vandetanib—thyroid cancer	0.00608	0.0322	CcSEcCtD
Tirofiban—Haemorrhage—Vandetanib—thyroid cancer	0.00604	0.032	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—TERT—thyroid cancer	0.00556	0.00791	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—BRAF—thyroid cancer	0.0055	0.00782	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—PRKAR1A—thyroid cancer	0.00496	0.00706	CbGpPWpGaD
Tirofiban—ITGB3—Platelet Aggregation (Plug Formation)—AKT1—thyroid cancer	0.00495	0.00703	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—AKT1—thyroid cancer	0.00489	0.00695	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—CDK1—thyroid cancer	0.00488	0.00694	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—BRAF—thyroid cancer	0.0046	0.00654	CbGpPWpGaD
Tirofiban—Hypertension—Vandetanib—thyroid cancer	0.00454	0.024	CcSEcCtD
Tirofiban—Myocardial infarction—Sorafenib—thyroid cancer	0.00445	0.0236	CcSEcCtD
Tirofiban—Haematemesis—Epirubicin—thyroid cancer	0.00432	0.0229	CcSEcCtD
Tirofiban—Oedema—Vandetanib—thyroid cancer	0.00429	0.0227	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—BRAF—thyroid cancer	0.00427	0.00607	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Vandetanib—thyroid cancer	0.0042	0.0223	CcSEcCtD
Tirofiban—Haemoglobin—Sorafenib—thyroid cancer	0.0041	0.0217	CcSEcCtD
Tirofiban—Haemorrhage—Sorafenib—thyroid cancer	0.00408	0.0216	CcSEcCtD
Tirofiban—Haemoptysis—Epirubicin—thyroid cancer	0.00405	0.0215	CcSEcCtD
Tirofiban—Haematemesis—Doxorubicin—thyroid cancer	0.004	0.0212	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—PRKAR1A—thyroid cancer	0.00382	0.00544	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—AKT1—thyroid cancer	0.00377	0.00536	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—CDK1—thyroid cancer	0.00376	0.00535	CbGpPWpGaD
Tirofiban—Haemoptysis—Doxorubicin—thyroid cancer	0.00375	0.0199	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—CALCB—thyroid cancer	0.00369	0.00525	CbGpPWpGaD
Tirofiban—Pain—Vandetanib—thyroid cancer	0.00367	0.0194	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—TRIM33—thyroid cancer	0.0035	0.00498	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—CDK1—thyroid cancer	0.00348	0.00495	CbGpPWpGaD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—NRAS—thyroid cancer	0.00348	0.00495	CbGpPWpGaD
Tirofiban—Body temperature increased—Vandetanib—thyroid cancer	0.00339	0.018	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—BRAF—thyroid cancer	0.00329	0.00468	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—IFNA2—thyroid cancer	0.00329	0.00467	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—HRAS—thyroid cancer	0.00328	0.00467	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—NRAS—thyroid cancer	0.00327	0.00465	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—AKT1—thyroid cancer	0.00327	0.00465	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—PTEN—thyroid cancer	0.00324	0.00461	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—RXRA—thyroid cancer	0.00323	0.0046	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—AKT1—thyroid cancer	0.00323	0.00459	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—CCND1—thyroid cancer	0.00321	0.00457	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—CCND1—thyroid cancer	0.00312	0.00443	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—NRAS—thyroid cancer	0.00309	0.00439	CbGpPWpGaD
Tirofiban—Hypertension—Sorafenib—thyroid cancer	0.00306	0.0162	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—thyroid cancer	0.00304	0.00432	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—PTEN—thyroid cancer	0.00301	0.00428	CbGpPWpGaD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—KRAS—thyroid cancer	0.003	0.00426	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—AKT1—thyroid cancer	0.0029	0.00413	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—AKT1—thyroid cancer	0.0029	0.00412	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Sorafenib—thyroid cancer	0.0029	0.0153	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—NRAS—thyroid cancer	0.00289	0.00411	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CALCB—thyroid cancer	0.00285	0.00405	CbGpPWpGaD
Tirofiban—Dizziness—Vandetanib—thyroid cancer	0.00284	0.015	CcSEcCtD
Tirofiban—Thrombocytopenia—Sorafenib—thyroid cancer	0.00284	0.015	CcSEcCtD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—KRAS—thyroid cancer	0.00282	0.00401	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TRIM33—thyroid cancer	0.0027	0.00384	CbGpPWpGaD
Tirofiban—Headache—Vandetanib—thyroid cancer	0.00269	0.0142	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—CDK1—thyroid cancer	0.00268	0.00382	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—KRAS—thyroid cancer	0.00266	0.00378	CbGpPWpGaD
Tirofiban—Nausea—Vandetanib—thyroid cancer	0.00255	0.0135	CcSEcCtD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—HRAS—thyroid cancer	0.00255	0.00362	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—IFNA2—thyroid cancer	0.00253	0.0036	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—HRAS—thyroid cancer	0.00253	0.00359	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—RXRA—thyroid cancer	0.00249	0.00354	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—KRAS—thyroid cancer	0.00249	0.00354	CbGpPWpGaD
Tirofiban—Pain—Sorafenib—thyroid cancer	0.00248	0.0131	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—CCND1—thyroid cancer	0.0024	0.00341	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—HRAS—thyroid cancer	0.00239	0.00341	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TCF7L1—thyroid cancer	0.00234	0.00332	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—PTEN—thyroid cancer	0.00232	0.0033	CbGpPWpGaD
Tirofiban—Urticaria—Sorafenib—thyroid cancer	0.0023	0.0122	CcSEcCtD
Tirofiban—Body temperature increased—Sorafenib—thyroid cancer	0.00229	0.0121	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—HRAS—thyroid cancer	0.00226	0.00321	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—AKT1—thyroid cancer	0.00223	0.00317	CbGpPWpGaD
Tirofiban—Hypersensitivity—Sorafenib—thyroid cancer	0.00213	0.0113	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—TP53—thyroid cancer	0.00212	0.00301	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—HRAS—thyroid cancer	0.00211	0.00301	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—AKT1—thyroid cancer	0.00211	0.00301	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—PPARG—thyroid cancer	0.00204	0.0029	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—AKT1—thyroid cancer	0.002	0.00284	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—HRAS—thyroid cancer	0.00196	0.00279	CbGpPWpGaD
Tirofiban—Dizziness—Sorafenib—thyroid cancer	0.00192	0.0101	CcSEcCtD
Tirofiban—Headache—Sorafenib—thyroid cancer	0.00181	0.00961	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—TCF7L1—thyroid cancer	0.0018	0.00256	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—AKT1—thyroid cancer	0.00179	0.00254	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—NRAS—thyroid cancer	0.00175	0.00249	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—AKT1—thyroid cancer	0.00173	0.00247	CbGpPWpGaD
Tirofiban—Nausea—Sorafenib—thyroid cancer	0.00172	0.00911	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—TSHR—thyroid cancer	0.00171	0.00243	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PRKAR1A—thyroid cancer	0.00168	0.00239	CbGpPWpGaD
Tirofiban—Sweating—Epirubicin—thyroid cancer	0.00161	0.00852	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—MEN1—thyroid cancer	0.00161	0.00229	CbGpPWpGaD
Tirofiban—Haematuria—Epirubicin—thyroid cancer	0.0016	0.00847	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—PPARG—thyroid cancer	0.00157	0.00224	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.00154	0.00218	CbGpPWpGaD
Tirofiban—Bradycardia—Epirubicin—thyroid cancer	0.00153	0.00812	CcSEcCtD
Tirofiban—Haemoglobin—Epirubicin—thyroid cancer	0.00151	0.00802	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—HRAS—thyroid cancer	0.00151	0.00215	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—KRAS—thyroid cancer	0.00151	0.00214	CbGpPWpGaD
Tirofiban—Haemorrhage—Epirubicin—thyroid cancer	0.00151	0.00798	CcSEcCtD
Tirofiban—Sweating—Doxorubicin—thyroid cancer	0.00149	0.00788	CcSEcCtD
Tirofiban—Haematuria—Doxorubicin—thyroid cancer	0.00148	0.00784	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—PTCH1—thyroid cancer	0.00145	0.00207	CbGpPWpGaD
Tirofiban—Bradycardia—Doxorubicin—thyroid cancer	0.00142	0.00751	CcSEcCtD
Tirofiban—Haemoglobin—Doxorubicin—thyroid cancer	0.0014	0.00742	CcSEcCtD
Tirofiban—Haemorrhage—Doxorubicin—thyroid cancer	0.00139	0.00738	CcSEcCtD
Tirofiban—Chills—Epirubicin—thyroid cancer	0.00135	0.00716	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—NRAS—thyroid cancer	0.00135	0.00192	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—AKT1—thyroid cancer	0.00134	0.0019	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SST—thyroid cancer	0.00133	0.00189	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TSHR—thyroid cancer	0.00132	0.00187	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PRKAR1A—thyroid cancer	0.0013	0.00184	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—HRAS—thyroid cancer	0.00128	0.00182	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CALCA—thyroid cancer	0.00128	0.00182	CbGpPWpGaD
Tirofiban—Chills—Doxorubicin—thyroid cancer	0.00125	0.00662	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—NRAS—thyroid cancer	0.00125	0.00178	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MEN1—thyroid cancer	0.00124	0.00176	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—NRAS—thyroid cancer	0.00123	0.00174	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.00118	0.00168	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—KRAS—thyroid cancer	0.00116	0.00165	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CDK1—thyroid cancer	0.00116	0.00165	CbGpPWpGaD
Tirofiban—Hypertension—Epirubicin—thyroid cancer	0.00113	0.00599	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—PTCH1—thyroid cancer	0.00112	0.00159	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—KRAS—thyroid cancer	0.00108	0.00153	CbGpPWpGaD
Tirofiban—Oedema—Epirubicin—thyroid cancer	0.00107	0.00567	CcSEcCtD
Tirofiban—Anaphylactic shock—Epirubicin—thyroid cancer	0.00107	0.00567	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—KRAS—thyroid cancer	0.00106	0.0015	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Epirubicin—thyroid cancer	0.00105	0.00555	CcSEcCtD
Tirofiban—Hypertension—Doxorubicin—thyroid cancer	0.00105	0.00555	CcSEcCtD
Tirofiban—Hyperhidrosis—Epirubicin—thyroid cancer	0.00103	0.00548	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—SST—thyroid cancer	0.00102	0.00146	CbGpPWpGaD
Tirofiban—Oedema—Doxorubicin—thyroid cancer	0.000991	0.00524	CcSEcCtD
Tirofiban—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000991	0.00524	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—HRAS—thyroid cancer	0.000987	0.0014	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CALCA—thyroid cancer	0.000986	0.0014	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00097	0.00513	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—NRAS—thyroid cancer	0.000963	0.00137	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000958	0.00507	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—NRAS—thyroid cancer	0.000945	0.00134	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TP53—thyroid cancer	0.000938	0.00133	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NRG1—thyroid cancer	0.00093	0.00132	CbGpPWpGaD
Tirofiban—Pain—Epirubicin—thyroid cancer	0.000915	0.00485	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—HRAS—thyroid cancer	0.000914	0.0013	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—HRAS—thyroid cancer	0.000897	0.00128	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CDK1—thyroid cancer	0.000893	0.00127	CbGpPWpGaD
Tirofiban—Urticaria—Epirubicin—thyroid cancer	0.00085	0.0045	CcSEcCtD
Tirofiban—Pain—Doxorubicin—thyroid cancer	0.000847	0.00448	CcSEcCtD
Tirofiban—Body temperature increased—Epirubicin—thyroid cancer	0.000846	0.00448	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—TERT—thyroid cancer	0.000835	0.00119	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—KRAS—thyroid cancer	0.000829	0.00118	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—KRAS—thyroid cancer	0.000813	0.00116	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—AKT1—thyroid cancer	0.000807	0.00115	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HIF1A—thyroid cancer	0.000799	0.00114	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—AKT1—thyroid cancer	0.000792	0.00113	CbGpPWpGaD
Tirofiban—Hypersensitivity—Epirubicin—thyroid cancer	0.000789	0.00417	CcSEcCtD
Tirofiban—Urticaria—Doxorubicin—thyroid cancer	0.000787	0.00417	CcSEcCtD
Tirofiban—Body temperature increased—Doxorubicin—thyroid cancer	0.000783	0.00414	CcSEcCtD
Tirofiban—Hypersensitivity—Doxorubicin—thyroid cancer	0.00073	0.00386	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—TP53—thyroid cancer	0.000723	0.00103	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NRG1—thyroid cancer	0.000717	0.00102	CbGpPWpGaD
Tirofiban—Dizziness—Epirubicin—thyroid cancer	0.000708	0.00375	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—HRAS—thyroid cancer	0.000704	0.001	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—HRAS—thyroid cancer	0.000691	0.000982	CbGpPWpGaD
Tirofiban—Headache—Epirubicin—thyroid cancer	0.000671	0.00355	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—BRAF—thyroid cancer	0.000661	0.00094	CbGpPWpGaD
Tirofiban—Dizziness—Doxorubicin—thyroid cancer	0.000655	0.00347	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—TERT—thyroid cancer	0.000643	0.000915	CbGpPWpGaD
Tirofiban—Nausea—Epirubicin—thyroid cancer	0.000636	0.00337	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—AKT1—thyroid cancer	0.000622	0.000884	CbGpPWpGaD
Tirofiban—Headache—Doxorubicin—thyroid cancer	0.000621	0.00328	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—HIF1A—thyroid cancer	0.000615	0.000875	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—AKT1—thyroid cancer	0.00061	0.000868	CbGpPWpGaD
Tirofiban—Nausea—Doxorubicin—thyroid cancer	0.000588	0.00311	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—BRAF—thyroid cancer	0.00051	0.000724	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CCND1—thyroid cancer	0.000483	0.000686	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PTEN—thyroid cancer	0.000466	0.000662	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NRAS—thyroid cancer	0.000416	0.000591	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCND1—thyroid cancer	0.000372	0.000529	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTEN—thyroid cancer	0.000359	0.00051	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—KRAS—thyroid cancer	0.000358	0.000509	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NRAS—thyroid cancer	0.00032	0.000455	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TP53—thyroid cancer	0.000318	0.000452	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HRAS—thyroid cancer	0.000304	0.000432	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—KRAS—thyroid cancer	0.000276	0.000392	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—AKT1—thyroid cancer	0.000269	0.000382	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TP53—thyroid cancer	0.000245	0.000348	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HRAS—thyroid cancer	0.000234	0.000333	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AKT1—thyroid cancer	0.000207	0.000294	CbGpPWpGaD
